 Because ultimately, if a new drug or a new treatment doesn't get to patients, what's the point? Dornsife thinks that a successful trial needs the patient perspective at many more parts in the process than just being the guinea pigs. Last year, we reported on Lupus ABC, a public-private partnership with the FDA that brought together patients and researchers to advance treatment together. This type of collaboration may be just what cancer trial research needs.